| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc04f5c89d8c275354dbd39188a766ff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-74 |
| filingDate |
1981-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971a89cb21fd21e5076d135ac6d507c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac5d1a7d9982aecdcb9ee8249603868 |
| publicationDate |
1985-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4495352-A |
| titleOfInvention |
Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols |
| abstract |
1-Aryloxy-3-[(3-indolyl)-tert.-butyl]amino-2-propanols having a heterocyclic aryl-attached substituent or aryl-fused heterocyclic ring are antihypertensive agents having vasodilator and adrenergic beta -receptor blocking action. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005030746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011054021-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006058391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7514473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8980950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8586631-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227914-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009163589-A1 |
| priorityDate |
1979-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |